Europlasma (1EZ0.F XETRA) down 13.33% 13 Jan 2026: liquidity, valuation risks
1EZ0.F stock closed sharply lower on XETRA on 13 Jan 2026, falling 13.33% to €0.13. Volume was 5,628 shares versus an average of 3,567, highlighting thin liquidity that amplified the decline. Intraday high was €0.18 and the session low was €0.13, leaving intraday range tight near the year low. Traders cited weak fundamentals, negative cash flows, and negative EPS of -88.61 as drivers. We examine price action, fundamentals, technicals, and the Meyka AI forecast to frame downside risk and short-term trade setups on the Germany XETRA market.
1EZ0.F stock: trading snapshot at XETRA close
Europlasma S.A. (1EZ0.F) finished the XETRA session at €0.13, down 13.33% from the prior close of €0.15. Market cap stands at €246,659 with 1,842,116 shares outstanding. Volume of 5,628 was 1.58x average, showing elevated activity but limited depth. Day high was €0.18 and day low €0.13, and the 50-day average is €0.37, while the 200-day average is €11.11.
1EZ0.F stock: fundamentals and valuation
Fundamentals are weak: trailing EPS is -88.61, book value per share is negative, and the company shows negative operating and free cash flow per share. Price to sales is 7.56 and EV/sales is 7.83, both high relative to revenue per share of €0.04. The current ratio is 0.77, signalling short-term liquidity strain. These metrics point to elevated valuation risk versus operating scale in waste management.
1EZ0.F stock: technicals and momentum
Short-term technicals show downside momentum. RSI is 32.84 and the CCI is -128.72, both near oversold territory. MACD sits slightly negative with a small histogram. Bollinger Bands middle is €0.25 and lower band €0.15, which frames immediate support. The stock shows no clear trend (ADX 14.24), so volume spikes can move price quickly.
Meyka AI rates 1EZ0.F with a score out of 100 and forecast
Meyka AI rates 1EZ0.F with a score out of 100: 66.50 (Grade B, Suggestion: HOLD). This grade factors S&P 500 and sector comparisons, financial growth, key metrics, analyst consensus, and forecasts. Meyka AI’s forecast model projects a 12-month fair price of €0.05, compared with current price EUR 0.1339, implying -62.70% downside. Forecasts are model-based projections and not guarantees. For company detail see Europlasma website and Europlasma profile on Meyka for live metrics.
1EZ0.F stock: risks, catalysts and sector context
Key risks include weak margins, negative cash flow, and low liquidity that can widen spreads on XETRA. Interest coverage is negative and working capital is strained, increasing refinancing risk for an industrial waste company. Catalysts that could stabilise price include contract wins in hazardous waste processing or a capital raise. The industrials waste management sector shows mixed demand, so company-specific wins matter more than sector tailwinds.
1EZ0.F stock: trading strategy and price levels
Short-term traders should note immediate support near €0.13 and resistance at the day high €0.18 and Bollinger middle €0.25. The 50-day average at €0.37 is far above current levels and acts as a distant resistance. Given volatility and thin liquidity, position sizing should be small. Longer-term investors should wait for improved cash flow and consistent earnings before adding exposure.
Final Thoughts
Europlasma (1EZ0.F stock) closed the XETRA session on 13 Jan 2026 at €0.13, down 13.33%, on volume of 5,628, underscoring thin liquidity and headline weakness. Fundamentals are the primary concern: EPS is -88.61, price-to-sales is 7.56, and cash flow per share is negative. Meyka AI rates 1EZ0.F with a score of 66.50 (Grade B, Suggestion: HOLD) after blending benchmark, sector, and company metrics. Meyka AI’s forecast model projects a 12-month price of €0.05, versus the current price EUR 0.1339, implying -62.70% downside. Forecasts are model-based projections and not guarantees. In our view, the stock remains a high-risk holding on XETRA, suited only for traders who accept significant liquidity and execution risk. Monitor cash flow improvement, contract announcements, or a clear capital structure fix before increasing exposure. For live updates and screeners see the Meyka AI-powered market analysis platform and the company site for filings Europlasma website.
FAQs
What drove the 13.33% drop in 1EZ0.F stock on 13 Jan 2026?
The fall reflected thin liquidity, negative earnings (EPS -88.61), and weak cash flows. Volume spiked to 5,628 against an average of 3,567, which magnified selling pressure on XETRA.
What is Meyka AI’s view on 1EZ0.F stock?
Meyka AI rates 1EZ0.F at 66.50 out of 100 (Grade B, Suggestion: HOLD). The model flags liquidity and valuation risk and projects a 12-month price of €0.05. Projections are not guarantees.
What are key support and resistance levels for 1EZ0.F stock?
Immediate support sits near the session low €0.13. Near-term resistance is €0.18 and Bollinger middle at €0.25. The 50-day average of €0.37 is a higher, longer-term resistance.
Should investors buy 1EZ0.F stock after the drop?
Given negative EPS, weak cash flow, and thin liquidity, buying is high risk. Wait for consistent operational improvements, cash flow recovery, or clearer capital structure before adding a meaningful position.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
